Search Results - "Ostroff, Gary"

Refine Results
  1. 1

    β-Glucan microparticles are good candidates for mucosal antigen delivery in oral vaccination by De Smet, Rebecca, Demoor, Tine, Verschuere, Stephanie, Dullaers, Melissa, Ostroff, Gary R., Leclercq, Georges, Allais, Liesbeth, Pilette, Charles, Dierendonck, Marijke, De Geest, Bruno G., Cuvelier, Claude A.

    Published in Journal of controlled release (28-12-2013)
    “…Continuously improving the developmental process and the efficacy of oral vaccines is essential in the fight against intestinal pathogens. A promising strategy…”
    Get full text
    Journal Article
  2. 2

    Yeast Particles for Encapsulation of Terpenes and Essential Oils by Soto, Ernesto R, Rus, Florentina, Mirza, Zeynep, Ostroff, Gary R

    Published in Molecules (Basel, Switzerland) (28-02-2023)
    “…Terpenes and essential oils are materials of great commercial use due to their broad spectra of antibacterial, antifungal, membrane permeation enhancement and…”
    Get full text
    Journal Article
  3. 3

    A glucan-particle based tularemia subunit vaccine induces T-cell immunity and affords partial protection in an inhalation rat infection model by Whelan, Adam O, Flick-Smith, Helen C, Walker, Nicola J, Abraham, Ambily, Levitz, Stuart M, Ostroff, Gary R, Oyston, Petra C F

    Published in PloS one (07-05-2024)
    “…Tularemia is a zoonotic disease caused by the facultative intracellular gram-negative bacterium Francisella tularensis. F. tularensis has a very low infection…”
    Get full text
    Journal Article
  4. 4

    Spectrum and mechanisms of inflammasome activation by chitosan by Bueter, Chelsea L, Lee, Chrono K, Wang, Jennifer P, Ostroff, Gary R, Specht, Charles A, Levitz, Stuart M

    Published in The Journal of immunology (1950) (15-06-2014)
    “…Chitosan, the deacetylated derivative of chitin, can be found in the cell wall of some fungi and is used in translational applications. We have shown that…”
    Get full text
    Journal Article
  5. 5

    Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation by Aouadi, Myriam, Tesz, Gregory J., Nicoloro, Sarah M., Wang, Mengxi, Chouinard, My, Soto, Ernesto, Ostroff, Gary R., Czech, Michael P.

    Published in Nature (30-04-2009)
    “…Special delivery for siRNAs The therapeutic potential of gene silencing with siRNAs (short interfering RNAs) is great — in theory. In practice many obstacles…”
    Get full text
    Journal Article
  6. 6

    Characterization of Multilayered Nanoparticles Encapsulated in Yeast Cell Wall Particles for DNA Delivery by Soto, Ernesto R, Ostroff, Gary R

    Published in Bioconjugate chemistry (01-04-2008)
    “…Nonviral gene delivery technologies have been developed using layer-by-layer self-assembly of nanomaterials held together by electrostatic interactions in…”
    Get full text
    Journal Article
  7. 7

    Yeast Particles Hyper-Loaded with Terpenes for Biocide Applications by Soto, Ernesto R, Rus, Florentina, Ostroff, Gary R

    Published in Molecules (Basel, Switzerland) (02-06-2022)
    “…Yeast particles (YPs) are 3−5 µm hollow and porous microspheres, a byproduct of some food grade yeast (Saccharomyces cerevisiae) extract manufacturing…”
    Get full text
    Journal Article
  8. 8

    Protection of mice against experimental cryptococcosis using glucan particle-based vaccines containing novel recombinant antigens by Hester, Maureen M., Lee, Chrono K., Abraham, Ambily, Khoshkenar, Payam, Ostroff, Gary R., Levitz, Stuart M., Specht, Charles A.

    Published in Vaccine (16-01-2020)
    “…•Cryptococcal protein antigens were recombinantly expressed in E. coli.•Two mouse strains were vaccinated with recombinant protein-filled glucan…”
    Get full text
    Journal Article
  9. 9

    Protection induced by a Francisella tularensis subunit vaccine delivered by glucan particles by Whelan, Adam O, Flick-Smith, Helen C, Homan, Jane, Shen, Zu T, Carpenter, Zoe, Khoshkenar, Payam, Abraham, Ambily, Walker, Nicola J, Levitz, Stuart M, Ostroff, Gary R, Oyston, Petra C F

    Published in PloS one (08-10-2018)
    “…Francisella tularensis is an intracellular pathogen causing the disease tularemia, and an organism of concern to biodefence. There is no licensed vaccine…”
    Get full text
    Journal Article
  10. 10

    A population of Langerin-positive dendritic cells in murine Peyer's patches involved in sampling β-glucan microparticles by De Jesus, Magdia, Ostroff, Gary R, Levitz, Stuart M, Bartling, Toni R, Mantis, Nicholas J

    Published in PloS one (14-03-2014)
    “…Glucan particles (GPs) are 2-4 μm hollow, porous shells composed of 1,3-β-D-glucan that have been effectively used for oral targeted-delivery of a wide range…”
    Get full text
    Journal Article
  11. 11

    An efficient (nano) silica - In glucan particles protein encapsulation approach for improved thermal stability by Soto, Ernesto R., Specht, Charles A., Rus, Florentina, Lee, Chrono K., Abraham, Ambily, Levitz, Stuart M., Ostroff, Gary R.

    Published in Journal of controlled release (01-05-2023)
    “…Glucan particles (GPs) are hollow, porous microspheres derived from Saccharomyces cerevisiae (Baker's yeast). The hollow cavity of GPs allows for efficient…”
    Get full text
    Journal Article
  12. 12

    A highly expressed intestinal cysteine protease of Ancylostoma ceylanicum protects vaccinated hamsters from hookworm infection by Noon, Jason B, Schwarz, Erich M, Ostroff, Gary R, Aroian, Raffi V

    Published in PLoS neglected tropical diseases (01-04-2019)
    “…Human hookworms (Necator americanus, Ancylostoma duodenale, and Ancylostoma ceylanicum) are intestinal blood-feeding parasites that infect ~500 million people…”
    Get full text
    Journal Article
  13. 13

    One Step Purification-Vaccine Delivery System by Soto, Ernesto R, Specht, Charles A, Lee, Chrono K, Levitz, Stuart M, Ostroff, Gary R

    Published in Pharmaceutics (01-05-2023)
    “…Glucan particles (GPs) are hollow, porous 3-5 µm microspheres derived from the cell walls of Baker's yeast ( ). Their 1,3-β-glucan outer shell allows for…”
    Get full text
    Journal Article
  14. 14

    Exploiting fungal cell wall components in vaccines by Levitz, Stuart M., Huang, Haibin, Ostroff, Gary R., Specht, Charles A.

    Published in Seminars in immunopathology (01-03-2015)
    “…Innate recognition of fungi leads to strong adaptive immunity. Investigators are trying to exploit this observation in vaccine development by combining…”
    Get full text
    Journal Article
  15. 15

    Beta-glucan-induced inflammatory monocytes mediate antitumor efficacy in the murine lung by Alexander, Matthew P., Fiering, Steven N., Ostroff, Gary R., Cramer, Robert A., Mullins, David W.

    Published in Cancer Immunology, Immunotherapy (01-11-2018)
    “…β-Glucan is a naturally occurring glucose polysaccharide with immunostimulatory activity in both infection and malignancy. β-Glucan’s antitumor effects have…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Anthelmintic Activity of Yeast Particle-Encapsulated Terpenes by Mirza, Zeynep, Soto, Ernesto R, Hu, Yan, Nguyen, Thanh-Thanh, Koch, David, Aroian, Raffi V, Ostroff, Gary R

    Published in Molecules (Basel, Switzerland) (27-06-2020)
    “…Soil-transmitted nematodes (STN) infect 1-2 billion of the poorest people worldwide. Only benzimidazoles are currently used in mass drug administration, with…”
    Get full text
    Journal Article
  18. 18

    Characterization and Optimization of the Glucan Particle-Based Vaccine Platform by Huang, Haibin, Ostroff, Gary R, Lee, Chrono K, Specht, Charles A, Levitz, Stuart M

    Published in Clinical and Vaccine Immunology (01-10-2013)
    “…Classifications Services CVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Yeast Particle Encapsulation of Azole Fungicides for Enhanced Treatment of Azole-Resistant Candida albicans by Soto, Ernesto R, Rus, Florentina, Ostroff, Gary R

    Published in Journal of functional biomaterials (23-07-2024)
    “…Addressing the growing problem of antifungal resistance in medicine and agriculture requires the development of new drugs and strategies to preserve the…”
    Get full text
    Journal Article